CRP and familial hypercholesterolemia: In a pooled analysis of randomized, placebo-controlled trials of patients with hypercholesterolemia, the addition of ezetimibe to statin treatment significantly reduced C-reactive protein over statin monotherapy, although further studies are needed to validate this concept23.